Financials data is unavailable for this security.
View more
Year on year Legend Biotech Corp had net income fall 16.11% from a loss of 446.35m to a larger loss of 518.25m despite a 143.70% increase in revenues from 117.01m to 285.14m.
Gross margin | 60.28% |
---|---|
Net profit margin | -62.50% |
Operating margin | -81.89% |
Return on assets | -15.29% |
---|---|
Return on equity | -22.21% |
Return on investment | -17.63% |
More ▼
Cash flow in USDView more
In 2023, Legend Biotech Corp increased its cash reserves by 62.55%, or 491.68m. Cash Flow from Financing totalled 791.49m or 277.58% of revenues. In addition the company used 393.28m for operations while cash from investing totalled 92.79m.
Cash flow per share | -1.45 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.33 |
---|---|
Tangible book value per share | 6.31 |
More ▼
Balance sheet in USDView more
Current ratio | 4.84 |
---|---|
Quick ratio | 4.78 |
Total debt/total equity | 0.2924 |
---|---|
Total debt/total capital | 0.2263 |
More ▼